Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
The Associazione Italiana di Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Acute Lymphoblastic Leukemia (AIEOP-BFM ALL 2000) study has for the first time introduced standardized quantitative assessment of minimal residual disease (MRD) based on immunoglobulin and T-cell receptor...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
14 December 2020
|
| In: |
Blood
Year: 2010, Volume: 115, Issue: 16, Pages: 3206-3214 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2009-10-248146 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood-2009-10-248146 |
| Author Notes: | Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi, André Schrauder, Renate Panzer-Grümayer, Anja Möricke, Maurizio Aricò, Martin Zimmermann, Georg Mann, Giulio De Rossi, Martin Stanulla, Franco Locatelli, Giuseppe Basso, Felix Niggli, Elena Barisone, Günter Henze, Wolf-Dieter Ludwig, Oskar A. Haas, Giovanni Cazzaniga, Rolf Koehler, Daniela Silvestri, Jutta Bradtke, Rosanna Parasole, Rita Beier, Jacques J.M. van Dongen, Andrea Biondi, and Martin Schrappe |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1847529275 | ||
| 003 | DE-627 | ||
| 005 | 20230710131438.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230606s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood-2009-10-248146 |2 doi | |
| 035 | |a (DE-627)1847529275 | ||
| 035 | |a (DE-599)KXP1847529275 | ||
| 035 | |a (OCoLC)1389794252 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Conter, Valentino |e VerfasserIn |0 (DE-588)1292160748 |0 (DE-627)1847532551 |4 aut | |
| 245 | 1 | 0 | |a Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia |b results in 3184 patients of the AIEOP-BFM ALL 2000 study |c Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi, André Schrauder, Renate Panzer-Grümayer, Anja Möricke, Maurizio Aricò, Martin Zimmermann, Georg Mann, Giulio De Rossi, Martin Stanulla, Franco Locatelli, Giuseppe Basso, Felix Niggli, Elena Barisone, Günter Henze, Wolf-Dieter Ludwig, Oskar A. Haas, Giovanni Cazzaniga, Rolf Koehler, Daniela Silvestri, Jutta Bradtke, Rosanna Parasole, Rita Beier, Jacques J.M. van Dongen, Andrea Biondi, and Martin Schrappe |
| 264 | 1 | |c 14 December 2020 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.06.2023 | ||
| 520 | |a The Associazione Italiana di Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Acute Lymphoblastic Leukemia (AIEOP-BFM ALL 2000) study has for the first time introduced standardized quantitative assessment of minimal residual disease (MRD) based on immunoglobulin and T-cell receptor gene rearrangements as polymerase chain reaction targets (PCR-MRD), at 2 time points (TPs), to stratify patients in a large prospective study. Patients with precursor B (pB) ALL (n = 3184) were considered MRD standard risk (MRD-SR) if MRD was already negative at day 33 (analyzed by 2 markers, with a sensitivity of at least 10(-4)); MRD high risk (MRD-HR) if 10(-3) or more at day 78 and MRD intermediate risk (MRD-IR): others. MRD-SR patients were 42% (1348): 5-year event-free survival (EFS, standard error) is 92.3% (0.9). Fifty-two percent (1647) were MRD-IR: EFS 77.6% (1.3). Six percent of patients (189) were MRD-HR: EFS 50.1% (4.1; P < .001). PCR-MRD discriminated prognosis even on top of white blood cell count, age, early response to prednisone, and genotype. MRD response detected by sensitive quantitative PCR at 2 predefined TPs is highly predictive for relapse in childhood pB-ALL. The study is registered at http://clinicaltrials.gov: NCT00430118 for BFM and NCT00613457 for AIEOP. | ||
| 650 | 4 | |a Adolescent | |
| 650 | 4 | |a Antineoplastic Combined Chemotherapy Protocols | |
| 650 | 4 | |a Biomarkers, Tumor | |
| 650 | 4 | |a Child | |
| 650 | 4 | |a Child, Preschool | |
| 650 | 4 | |a Disease-Free Survival | |
| 650 | 4 | |a Gene Rearrangement, B-Lymphocyte | |
| 650 | 4 | |a Gene Rearrangement, T-Lymphocyte | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Infant | |
| 650 | 4 | |a Kaplan-Meier Estimate | |
| 650 | 4 | |a Neoplasm, Residual | |
| 650 | 4 | |a Precursor Cell Lymphoblastic Leukemia-Lymphoma | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Receptors, Antigen, B-Cell | |
| 650 | 4 | |a Receptors, Antigen, T-Cell | |
| 650 | 4 | |a Remission Induction | |
| 650 | 4 | |a Reverse Transcriptase Polymerase Chain Reaction | |
| 650 | 4 | |a Treatment Outcome | |
| 700 | 1 | |a Bartram, Claus R. |d 1952- |e VerfasserIn |0 (DE-588)139758518 |0 (DE-627)613089502 |0 (DE-576)312997159 |4 aut | |
| 700 | 1 | |a Valsecchi, Maria Grazia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schrauder, André |e VerfasserIn |4 aut | |
| 700 | 1 | |a Panzer-Grümayer, Renate |e VerfasserIn |4 aut | |
| 700 | 1 | |a Möricke, Anja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Aricò, Maurizio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zimmermann, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mann, Georg |e VerfasserIn |4 aut | |
| 700 | 1 | |a De Rossi, Giulio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stanulla, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Locatelli, Franco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Basso, Giuseppe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Niggli, Felix |e VerfasserIn |4 aut | |
| 700 | 1 | |a Barisone, Elena |e VerfasserIn |4 aut | |
| 700 | 1 | |a Henze, Günter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ludwig, Wolf-Dieter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haas, Oskar A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cazzaniga, Giovanni |e VerfasserIn |4 aut | |
| 700 | 1 | |a Köhler, Rolf |d 1966- |e VerfasserIn |0 (DE-588)12289751X |0 (DE-627)082221545 |0 (DE-576)293468427 |4 aut | |
| 700 | 1 | |a Silvestri, Daniela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bradtke, Jutta |e VerfasserIn |4 aut | |
| 700 | 1 | |a Parasole, Rosanna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Beier, Rita |e VerfasserIn |4 aut | |
| 700 | 1 | |a van Dongen, Jacques J. M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Biondi, Andrea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schrappe, Martin |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 115(2010), 16, Seite 3206-3214 |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia results in 3184 patients of the AIEOP-BFM ALL 2000 study |
| 773 | 1 | 8 | |g volume:115 |g year:2010 |g number:16 |g pages:3206-3214 |g extent:9 |a Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia results in 3184 patients of the AIEOP-BFM ALL 2000 study |
| 856 | 4 | 0 | |u https://doi.org/10.1182/blood-2009-10-248146 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230606 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 12289751X |a Köhler, Rolf |m 12289751X:Köhler, Rolf |d 910000 |d 911500 |e 910000PK12289751X |e 911500PK12289751X |k 0/910000/ |k 1/910000/911500/ |p 20 | ||
| 998 | |g 139758518 |a Bartram, Claus R. |m 139758518:Bartram, Claus R. |d 910000 |d 911500 |d 910000 |e 910000PB139758518 |e 911500PB139758518 |e 910000PB139758518 |k 0/910000/ |k 1/910000/911500/ |k 0/910000/ |p 2 | ||
| 999 | |a KXP-PPN1847529275 |e 4329671255 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"14 December 2020","dateIssuedKey":"2010"}],"language":["eng"],"relHost":[{"id":{"zdb":["1468538-3"],"eki":["266886647"],"issn":["1528-0020"]},"recId":"266886647","pubHistory":["1.1946 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"issue":"16","year":"2010","pages":"3206-3214","volume":"115","text":"115(2010), 16, Seite 3206-3214","extent":"9"},"title":[{"title":"Blood","subtitle":"journal of the American Society of Hematology","title_sort":"Blood"}],"titleAlt":[{"title":"Blood online"}],"corporate":[{"display":"American Society of Hematology","roleDisplay":"Herausgebendes Organ","role":"isb"}],"origin":[{"dateIssuedKey":"1946","dateIssuedDisp":"1946-","publisher":"American Society of Hematology ; Saunders ; HighWire Press","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif."}],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 21.04.2023"],"language":["eng"],"disp":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia results in 3184 patients of the AIEOP-BFM ALL 2000 studyBlood"}],"physDesc":[{"extent":"9 S."}],"note":["Gesehen am 06.06.2023"],"name":{"displayForm":["Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi, André Schrauder, Renate Panzer-Grümayer, Anja Möricke, Maurizio Aricò, Martin Zimmermann, Georg Mann, Giulio De Rossi, Martin Stanulla, Franco Locatelli, Giuseppe Basso, Felix Niggli, Elena Barisone, Günter Henze, Wolf-Dieter Ludwig, Oskar A. Haas, Giovanni Cazzaniga, Rolf Koehler, Daniela Silvestri, Jutta Bradtke, Rosanna Parasole, Rita Beier, Jacques J.M. van Dongen, Andrea Biondi, and Martin Schrappe"]},"recId":"1847529275","id":{"doi":["10.1182/blood-2009-10-248146"],"eki":["1847529275"]},"title":[{"subtitle":"results in 3184 patients of the AIEOP-BFM ALL 2000 study","title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia","title_sort":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia"}],"person":[{"role":"aut","family":"Conter","roleDisplay":"VerfasserIn","given":"Valentino","display":"Conter, Valentino"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Bartram, Claus R.","given":"Claus R.","family":"Bartram"},{"role":"aut","family":"Valsecchi","display":"Valsecchi, Maria Grazia","roleDisplay":"VerfasserIn","given":"Maria Grazia"},{"family":"Schrauder","roleDisplay":"VerfasserIn","given":"André","display":"Schrauder, André","role":"aut"},{"role":"aut","family":"Panzer-Grümayer","roleDisplay":"VerfasserIn","display":"Panzer-Grümayer, Renate","given":"Renate"},{"role":"aut","family":"Möricke","roleDisplay":"VerfasserIn","display":"Möricke, Anja","given":"Anja"},{"display":"Aricò, Maurizio","roleDisplay":"VerfasserIn","given":"Maurizio","family":"Aricò","role":"aut"},{"given":"Martin","roleDisplay":"VerfasserIn","display":"Zimmermann, Martin","family":"Zimmermann","role":"aut"},{"given":"Georg","roleDisplay":"VerfasserIn","display":"Mann, Georg","family":"Mann","role":"aut"},{"family":"De Rossi","roleDisplay":"VerfasserIn","given":"Giulio","display":"De Rossi, Giulio","role":"aut"},{"family":"Stanulla","roleDisplay":"VerfasserIn","display":"Stanulla, Martin","given":"Martin","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Locatelli, Franco","given":"Franco","family":"Locatelli"},{"roleDisplay":"VerfasserIn","display":"Basso, Giuseppe","given":"Giuseppe","family":"Basso","role":"aut"},{"family":"Niggli","roleDisplay":"VerfasserIn","given":"Felix","display":"Niggli, Felix","role":"aut"},{"role":"aut","given":"Elena","roleDisplay":"VerfasserIn","display":"Barisone, Elena","family":"Barisone"},{"roleDisplay":"VerfasserIn","given":"Günter","display":"Henze, Günter","family":"Henze","role":"aut"},{"role":"aut","family":"Ludwig","roleDisplay":"VerfasserIn","given":"Wolf-Dieter","display":"Ludwig, Wolf-Dieter"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Oskar A.","display":"Haas, Oskar A.","family":"Haas"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Cazzaniga, Giovanni","given":"Giovanni","family":"Cazzaniga"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Rolf","display":"Köhler, Rolf","family":"Köhler"},{"given":"Daniela","roleDisplay":"VerfasserIn","display":"Silvestri, Daniela","family":"Silvestri","role":"aut"},{"role":"aut","family":"Bradtke","roleDisplay":"VerfasserIn","display":"Bradtke, Jutta","given":"Jutta"},{"family":"Parasole","roleDisplay":"VerfasserIn","display":"Parasole, Rosanna","given":"Rosanna","role":"aut"},{"role":"aut","family":"Beier","roleDisplay":"VerfasserIn","given":"Rita","display":"Beier, Rita"},{"family":"van Dongen","given":"Jacques J. M.","roleDisplay":"VerfasserIn","display":"van Dongen, Jacques J. M.","role":"aut"},{"given":"Andrea","roleDisplay":"VerfasserIn","display":"Biondi, Andrea","family":"Biondi","role":"aut"},{"role":"aut","family":"Schrappe","roleDisplay":"VerfasserIn","display":"Schrappe, Martin","given":"Martin"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a CONTERVALEMOLECULARR1420 | ||